To explore the underlying mechanisms of the anti-metastatic actions of LCN2 in osteosarcoma cells, we conducted a transcriptomic analysis of U2OS cells transfected with siRNA inhibiting human LCN2 for 24 h using RNA sequencing technology. Here, LCN2 is linked to osteosarcoma.